Pretreatment prevalence of hypothyroidism in patients with head and neck carcinoma
โ Scribed by Sharon Mini; Shay Dori; Zeev Horowitz; Lev Bedrin; Michael Peleg; Michael Wolf; Yitzhak Shoshani; Shlomo Taicher; Jona Kronenberg; Yoav P. Talmi
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 70 KB
- Volume
- 92
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Data pertaining to tumor origin, spread, treatment, and results were defined. Pain was assessed with the McGill Pain Questionnaire, using a 10-1 Department of Otolaryngology-Head and Neck point visual analogue scale (VAS) and a body map. Pain was diagnosed according Surgery, the Chaim Sheba Medical
Gm, A2m, and Km allotypic markers were examined in 40 Caucasian patients with squamous cell carcinomas of the head and neck. Serum IgA levels, the A2m(l) allotypic marker, and antibodies against IgAl, A2m(l), and A2m(2) were measured quantitatively. The frequency of Km(1) was found to be significant